Accuitis
Alpharetta, US · Georgia corporation
Founders & leadership
RJ
Robert Jason ThomasNamed on SEC filing
RC
Richard Charles CoulonNamed on SEC filing
SM
Stephen MartinNamed on SEC filing
GM
Geoff MeachamNamed on SEC filing
MS
Michael ShippelNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.8M disclosed across 2 rounds · 2015–2018
▶$1MraisedAug 2018 · 22 investors · BiotechnologyRule 506(b)
▶$1MraisedAug 2018 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Geoff MeachamDirector
- Robert Jason ThomasDirector
- Stephen MartinDirector
- Michael ShippelExecutive Officer, Director
- Richard Charles CoulonExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $10K
- Proceeds to insiders
- $75K
- First sale
- Jan 2018
- Incorporated
- Corporation, Georgia
- Federal exemptions
- 06b
▶$1.8MraisedSep 2017 · 15 investors · BiotechnologyRule 506(b)
▶$1.8MraisedSep 2017 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert Jason ThomasDirector
- Richard Charles CoulonExecutive Officer, Director
- Stephen MartinDirector
- Geoff MeachamDirector
- Michael ShippelExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.8M
- Minimum investment
- $10K
- Proceeds to insiders
- $75K
- First sale
- Jan 2015
- Incorporated
- Corporation, Georgia
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Accuitis raised?
- Accuitis has disclosed $2.8M raised across 2 rounds.
- Where is Accuitis headquartered?
- Accuitis is headquartered in Alpharetta, US.